Oppenheimer & Co’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.6K | Buy |
+10,500
| New | +$21K | ﹤0.01% | 1676 |
|
|
2025
Q4 | – | Sell |
-10,500
| Closed | -$13K | – | 1551 |
|
|
2025
Q3 | $13K | Hold |
10,500
| – | – | ﹤0.01% | 1644 |
|
|
2025
Q2 | $11.9K | Hold |
10,500
| – | – | ﹤0.01% | 1600 |
|
|
2025
Q1 | $15.3K | Hold |
10,500
| – | – | ﹤0.01% | 1558 |
|
|
2024
Q4 | $22.4K | Hold |
10,500
| – | – | ﹤0.01% | 1538 |
|
|
2024
Q3 | $29.4K | Hold |
10,500
| – | – | ﹤0.01% | 1493 |
|
|
2024
Q2 | $24.5K | Hold |
10,500
| – | – | ﹤0.01% | 1416 |
|
|
2024
Q1 | $46.9K | Sell |
10,500
-1,900
| -15% | -$7.93K | ﹤0.01% | 1410 |
|
|
2023
Q4 | $39.8K | Hold |
12,400
| – | – | ﹤0.01% | 1356 |
|
|
2023
Q3 | $39.3K | Hold |
12,400
| – | – | ﹤0.01% | 1350 |
|
|
2023
Q2 | $61.6K | Buy |
+12,400
| New | +$67.1K | ﹤0.01% | 1373 |
|
|
2022
Q4 | – | Sell |
-11,350
| Closed | -$123K | – | 1350 |
|
|
2022
Q3 | $123K | Sell |
11,350
-5,200
| -31% | -$70.7K | ﹤0.01% | 1281 |
|
|
2022
Q2 | $189K | Buy |
16,550
+1,500
| +10% | +$13.3K | ﹤0.01% | 1281 |
|
|
2022
Q1 | $137K | Buy |
15,050
+3,000
| +25% | +$31.2K | ﹤0.01% | 1399 |
|
|
2021
Q4 | $180K | Sell |
12,050
-1,095
| -8% | -$19.3K | ﹤0.01% | 1406 |
|
|
2021
Q3 | $338K | Sell |
13,145
-1,739
| -12% | -$41.3K | 0.01% | 1176 |
|
|
2021
Q2 | $388K | Sell |
14,884
-10,139
| -41% | -$289K | 0.01% | 1130 |
|
|
2021
Q1 | $883K | Buy |
+25,023
| New | +$844K | 0.02% | 749 |
|
|
2020
Q2 | – | Sell |
-13,300
| Closed | -$259K | – | 1257 |
|
|
2020
Q1 | $259K | Buy |
13,300
+5,500
| +71% | +$131K | 0.01% | 949 |
|
|
2019
Q4 | $203K | Sell |
7,800
-10,900
| -58% | -$300K | 0.01% | 1174 |
|
|
2019
Q3 | $510K | Buy |
18,700
+8,500
| +83% | +$242K | 0.01% | 786 |
|
|
2019
Q2 | $274K | Buy |
+10,200
| New | +$284K | 0.01% | 1038 |
|
Other funds holding ALLO
P
TGA
VCM
